The Chemours Company reports results for the quarter ended June 30 - Earnings Summary

The Chemours

04/08/2026 23:45

The Chemours Company CC.N reported quarterly adjusted earnings of 42 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 58 cents.  The mean expectation of ten analysts for the quarter was for earnings of 42 cents per share. Wall Street expected results to range from -19 cents to 56 cents per share.
Revenue fell 1.5% to $1.59 billion from a year ago; analysts expected $1.65 billion. 
The Chemours Company's reported EPS for the quarter was a loss of $1.81​.
The company reported a quarterly loss of $274 million.
The Chemours Company shares had fallen by 16.6% this quarter and gained 45.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 29.4% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the diversified chemicals peer group is  "buy."
Wall Street's median 12-month price target for Chemours Co is $25.50, about 29.7% above its last closing price of $17.93
This summary was machine generated from LSEG data August 4 at 10:45 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.42
0.42
Met
Mar. 31 2026 
-0.05
0.05
Beat
Dec. 31 2025 
0.07
0.05
Missed
Sep. 30 2025 
0.25
0.20
Missed